Early onset thyroid dysfunction after irradiation of head-and-neck squamous cell cancer: A prospective observational study
Annals of Oncology Research and Therapy · 2027
DOI: 10.4103/aort.aort_12_26 ↗Abstract
Abstract: BACKGROUND: Radiation therapy (RT) for squamous cell carcinoma of the head and neck (SCCHN) frequently exposes the thyroid gland to significant radiation doses, predisposing patients to radiation-induced hypothyroidism (RIHT). Early thyroid dysfunction is often under-recognized. This study aimed to evaluate the occurrence and predictors of early-onset RIHT within 6 months of RT completion. MATERIALS AND METHODS: This prospective observational study included 80 patients with stage I–IVb SCCHN and normal baseline thyroid function. Patients received definitive or adjuvant RT (60–70 Gy in 2 Gy fractions) with or without concurrent chemotherapy. Thyroid function tests (thyroid-stimulating hormone [TSH], total T3, and T4) were performed at baseline, 3 months, and 6 months posttreatment. Statistical analysis was conducted using SPSS v28, with P < 0.05 considered statistically significant. RESULTS: The mean age was 49.8 ± 11.07 years, with a male predominance (91%). A significant progressive rise in mean TSH levels was observed at 3 and 6 months compared to baseline ( P = 0.002), while T3 and T4 levels remained stable. Subclinical hypothyroidism (SHT) occurred in 3.7% of patients at 3 months and increased to 8% at 6 months. Higher occurrence was observed in patients aged ≥40 years, those with laryngeal or oropharyngeal primaries, and those receiving radiation doses ≥54 Gy. CONCLUSION: Early SHT was detected in 8% of patients within 6 months of RT. Radiation dose ≥54 Gy emerged as the most consistent predictor, supporting routine thyroid monitoring and careful planning to minimize radiation exposure to the thyroid gland in head-and-neck radiotherapy.
EUVIMED